Targeted filgrastim support in patients with early-stage breast carcinoma: toward the implementation of a risk model.

摘要: AMF Consulting Incorporated, Los Angeles, Cal-ifornia.The authors thank William Carter, Ph.D., and theOncology Practice Pattern Study Group for provid-ing the historic-control database. MaryAnn Foote,Ph.D., assisted with writing of this article.Additional members Neutropenia Risk ModelStudy include: Mitchell Alden, M.D., Bux-Mont Oncology/Hematology Medical Associates,Sellersville, PA; Francis P. Arena, Arena On-cology Associates, Great Neck, NY; John A. Axel-son, Hematology/Oncology Association ofSouthern Michigan, Jackson, MI; Suzanne T. Ber-lin, Addison-Gilbert Hospital, Gloucester, MA;Stephanie Bernstein, Faulkner Ja-maica Plains, MA; Rachel Borson, MidwestCancer Center, St. Louis, MO; Albert M. Brady,M.D., Joseph Mercy Oakland, Pontiac, Mi-chael S. Buchholtz, Hematology/Oncology,Huntington, Janak E. Choksi, AlamanceCancer Burlington, NC; Patrick Colarusso,M.D., Pottstown Memorial Cancer Potts-town, Elliot Dickman, Hillcrest HospitalCancer Mayfield Heights, OH; David Dun-ning, Northern Virginia Oncology Group, Fair-fax,VA;LeroyJ.Essig,M.D.,MedicalSpecialistsofFredericksburg, Fredericksburg, VA; Frank J.Forte, Staten Island University Hospital,Staten Island, Julio Garcia, Oncology/RadiationAssociates,Miami,FL;JeremyR.Geffen,M.D., Geffen Vero Beach, FL;Charles D. Graham, Trident Palmetto Hema-tology/Oncology, Charleston, SC; Andrew A.Hertler, Maine General Health, Waterville,ME; Karen L. Hoelzer, Springfield Clinica,Springfield, IL; Anthony Hoffman, SciodeMedical Association, Bronx, Leonard Kal-man, SouthFlorida, Miami, FL; Edward H. Kaplan, NorthShoreCancerResearch,Skokie,IL;JosephKaplan,M.D., Community Hematology/Oncology, Olney,MD; Kapisthalam Kumar, Pasco HernandoOncology New Port Richey, StevenS. Larmon, Dartmouth-Hitchcock Hospital,Keene, NH; James J. Lechner, WesternWashington Oncology, Olympia, WA; A.Lerner, Topilow, Lerner & Mencel, Man-asquan, NJ; Liebmann, Mex-ico Consultants, Albuquer-que, NM; Robert March, City, Leslie A.Martin, St Elizabeth’s Brigh-ton, O’Brien, The RegionalCancer Erie, Okerbloom, M.D.,Heartland Hematology, Council Bluffs,IA; Orsini, Essex Belleville, Stuart Packer,M.D., Langhorne, Sig-urdur R. Petursson, Western PennsylvaniaHospital, Pittsburgh, Debra Prow, M.D.,Texas Fort Worth, TX; Jane M.Raymond, Pennsylvania Hospital,Pittsburgh, Readling, LourdesRegional Binghamton, Joel H.Schwartz, North Shore Pea-body, Shiba, Gould Group,Modesto, CA; Michael Stender, Royal Oak, N. SimonTchekmedyian, Pacific Shores Group,Long Kathleen Toomey, SomersetHematology/Oncology, Somerset, Dean Tsar-whas, Oncology/Hematology, Lib-ertyville, Stephen Volk, Oncology/Hema-tology Lehigh Valley, Bethlehem, PivapongVongkovit, Northwestern Carolina Hickory, Marjorie Vukelich,M.D., Kettle Moraine West Bend, WI.Address reprints: Edgardo Rivera, Univer-sity Texas Anderson 1515Holcombe Blvd., Unit 424, Houston, TX 77030-0056; Fax: (713) 794-4385; E-mail: erivera@mail.mdanderson.orgReceived January 15, 2003; revision receivedMarch 28, accepted April 11, 2003.